Increase in intraocular pressure found to be tolerable to the corneal endothelium and safe for treating central serous chorioretinopathy or diabetic macular edema.
Jennifer DiSanto
Advertisement
Articles by Jennifer DiSanto
Increased virologic failure and drug resistance following dolutegravir monotherapy prompt researchers to recommend against its use in patients with HIV.
Advances in technology can guide insulin regimens prescribed at discharge among patients with diabetes.
Advertisement
Latest Updated Articles
HIV Monotherapy Shows Substantial Risk of HarmPublished: November 28th 2017 | Updated:
How Technology Can Improve Diabetes ManagementPublished: November 27th 2017 | Updated:
Bevacizumab Intravitreal Injection Intraocular Pressure Found Safe, TolerablePublished: February 12th 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
3
Doxecitine–Doxribtimine Becomes First Approved Treatment for Rare Genetic Disorder
4
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
5
